Market revenue in 2023 | USD 1,497.5 million |
Market revenue in 2030 | USD 2,883.9 million |
Growth rate | 9.8% (CAGR from 2023 to 2030) |
Largest segment | Anti-infective |
Fastest growing segment | Endocrinology |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Anti-Infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals |
Key market players worldwide | CVS Group PLC, Walgreens Boots Alliance Inc, UnitedHealth Group Inc, BrightSpring Health Services Inc, Fresenius Medical Care AG, ICU Medical Inc, B. Braun Medical, Baxter International Inc, BD, Smiths Group PLC, Terumo Corp, Caesarea Medical Electronics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to home infusion therapy market will help companies and investors design strategic landscapes.
Anti-infective was the largest segment with a revenue share of 26.76% in 2023. Horizon Databook has segmented the UK home infusion therapy market based on anti-infective, endocrinology, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition, specialty pharmaceuticals covering the revenue growth of each sub-segment from 2018 to 2030.
The home infusion therapy market in the UK is likely to grow at a steady rate during the forecast period. The country has well-established home care infrastructure. In addition, the presence of publicly funded home care services is contributing to market growth in the UK. Moreover, increasing number of initiatives undertaken by the government to promote patient safety pertaining to home infusion therapy is expected to drive market growth in the UK.
Furthermore, rising geriatric population coupled with rising prevalence of diseases such as Parkinson’s, arthritis, paralysis is anticipated to increase the demand for home infusion solutions. For instance, in the UK, one of the important economies in Europe, the geriatric population accounted for nearly 17.8% of the country’s population in 2015 and it is projected to reach approximately 24.6% by 2025.
Horizon Databook provides a detailed overview of country-level data and insights on the UK home infusion therapy market , including forecasts for subscribers. This country databook contains high-level insights into UK home infusion therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account